A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age Reduces the Risk of Stroke

• Atrial Fibrillation
• Atrial Flutter

• Zio®XT Monitor Arm
  Intervention: Other: Zio®XT Monitor
• No Intervention: Usual Care Arm

For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• Men and women at least 70 years of age who are new or established participants in the primary care practice
• Willing to provide consent to participate in the study and to use personal health information to ascertain endpoints from the Center for Medicare & Medicaid Services (CMS) Medicare Claims Database and to access data from health records
• Health insurance by Medicare Parts A & B (Medicare Fee-for-service)

Exclusion Criteria:

• Oral anticoagulation (OAC) for any indication at the time of enrollment
• History of Atrial Fibrillation (AF) or Atrial Flutter (AFL) as documented in the participant's current medical problem list
• Any condition the investigator considers a contraindication to OAC, e.g., bleeding that required medical attention or severe renal impairment
• Any condition the investigator considers will prevent compliance with study instructions
• Implanted cardiac devices (pacemakers, implantable cardiac defibrillators, or cardiac resynchronization therapy, and implantable loop recorders)
• History of allergy to adhesive

Other protocol-defined inclusion/exclusion criteria could apply